Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).

Evidence report/technology assessment

Volumn , Issue 146, 2007, Pages 1-77

  Matchar, David B ^a   Thakur, Mugdha E ^a   Grossman, Iris ^a   McCrory, Douglas C ^a   Orlando, Lori A ^a   Steffens, David C ^a   Goldstein, David B ^a   Cline, Kathryn E ^a   Gray, Rebecca N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYP2C19 PROTEIN, HUMAN; CYP2C9 PROTEIN, HUMAN; CYTOCHROME P450; CYTOCHROME P450 2D6; MIXED FUNCTION OXIDASE; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

DEPRESSION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETICS; GENOTYPE; HUMAN; MAJOR DEPRESSION; REVIEW; TREATMENT OUTCOME;

ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; GENETIC SCREENING; GENOTYPE; HUMANS; MIXED FUNCTION OXYGENASES; POLYMORPHISM, GENETIC; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 35248854448     PISSN: 15304396     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (111)